Canada markets closed

Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.60-0.05 (-0.65%)
At close: 04:00PM EDT
7.60 0.00 (0.00%)
After hours: 04:15PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.20B
Enterprise Value 1.82B
Trailing P/E 11.42
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.69
Price/Book (mrq)2.59
Enterprise Value/Revenue 4.11
Enterprise Value/EBITDA -1.97

Trading Information

Stock Price History

Beta (5Y Monthly) 0.55
52-Week Change 3-28.44%
S&P500 52-Week Change 321.61%
52 Week High 315.70
52 Week Low 37.53
50-Day Moving Average 310.63
200-Day Moving Average 310.43

Share Statistics

Avg Vol (3 month) 34.71M
Avg Vol (10 day) 32.36M
Shares Outstanding 5156.53M
Implied Shares Outstanding 6158.24M
Float 8137.03M
% Held by Insiders 12.08%
% Held by Institutions 1109.35%
Shares Short (Mar 28, 2024) 421.95M
Short Ratio (Mar 28, 2024) 42.87
Short % of Float (Mar 28, 2024) 422.85%
Short % of Shares Outstanding (Mar 28, 2024) 414.03%
Shares Short (prior month Feb 29, 2024) 415.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21194:1000
Last Split Date 3Apr 02, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -226.37%
Operating Margin (ttm)3.16%

Management Effectiveness

Return on Assets (ttm)13.39%
Return on Equity (ttm)-674.04%

Income Statement

Revenue (ttm)442.74M
Revenue Per Share (ttm)2.85
Quarterly Revenue Growth (yoy)9.70%
Gross Profit (ttm)N/A
EBITDA 169.91M
Net Income Avi to Common (ttm)-1B
Diluted EPS (ttm)-6.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)92.15M
Total Cash Per Share (mrq)0.59
Total Debt (mrq)715.54M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.85
Book Value Per Share (mrq)-2.21

Cash Flow Statement

Operating Cash Flow (ttm)183.43M
Levered Free Cash Flow (ttm)186.79M